A. Bruno

发表

Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States

A. Amin, J. Trocio, Jay Lin, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.

Robert A. Mendes, D. Dills, C. Zheng, 2015, Journal of managed care & specialty pharmacy.

Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies.

J. Trocio, J. Romley, J. Shafrin, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma

O. Lunacsek, J. Nelson, D. Stafkey-Mailey, 2020, Expert review of hematology.

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States

A. Amin, J. Trocio, Jay Lin, 2015, Journal of managed care & specialty pharmacy.

Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

V. Sikirica, P. Hodgkins, M. Fridman, 2013, Drugs in R&D.

Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.

M. B. Pereira, A. Kamburov, Jeran K Stratford, 2022, Cancer treatment and research communications.

Hemoglobin trends and anemia treatment resulting from concomitant chemotherapy in community oncology clinics.

B. Feinberg, J. Whyte, J. Gilmore, 2012, Journal of oncology practice.

Abstract 19672: Comparison of Major-bleeding Risk and Health Care Costs Among Treatment-naïve Non-valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

A. Amin, O. Baser, J. Trocio, 2015 .

Abstract 17609: Comparison of All-cause and Bleeding-related Hospitalizations Among Non-valvular Atrial Fibrillation Patients Receiving Oral Anticoagulants

J. Trocio, S. Deitelzweig, K. Gupta, 2015 .

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA

D. Globe, D. Barocas, T. Bramley, 2012, Advances in urology.

Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice

Robert A. Mendes, D. Dills, N. Rashid, 2015, Journal of the American Heart Association.

Economic Evaluations of Medical Cost Differences: Use of Targeted-SpecificOral Anticoagulants vs. Warfarin among Patients with Nonvalvular AtrialFibrillation and Venous Thromboembolism in the U.S.

A. Amin, J. Trocio, Jay Lin, 2015 .

Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US

A. Amin, J. Trocio, Jay Lin, 2015, Journal of medical economics.

Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early view

O. Baser, J. Trocio, J. Mardekian, 2016, Journal of medical economics.

Economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases.

D. Globe, Cheryl T. Lee, K. O’Day, 2012, The Journal of urology.

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States

G. Lip, J. Mardekian, C. Masseria, 2016, International journal of clinical practice.

Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.

F. Saad, N. Agarwal, K. Miller, 2021, Future oncology.

Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarin

J. Trocio, A. Farr, S. Johnston, 2014, Hospital practice.

Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation

J. Trocio, Jay Lin, S. Deitelzweig, 2016, Current medical research and opinion.

Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy

A. Wiland, A. Bruno, E. Zagadailov, 2013, Journal of transplantation.

An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants

J. Trocio, Jay Lin, S. Deitelzweig, 2016, Current medical research and opinion.

Greater fear of hypoglycaemia with premixed insulin than with basal‐bolus insulin glargine and glulisine: patient‐reported outcomes from a 60‐week randomised study

W. Polonsky, M. Riddle, A. Bruno, 2014, Diabetes, obesity & metabolism.

Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature.

M. Eaddy, R. Shenolikar, A. Bruno, 2011, American health & drug benefits.